SEC Tracker
Get the app

Halozyme Therapeutics HALO

Halozyme Therapeutics sells shares on Oct 1, 2026

Matthew L. Posard, insider filing for HALO

Form
4
Filed
Importance
Routine
  1. Matthew L. Posard sold 730 shares at $107.17
  2. Sold 3,300 shares at $108.45
  3. Sold 1,100 shares at $109.57
  4. Sold 100 shares at $110.04

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Halozyme Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Axsome Therapeutics AXSM public float $4.4B, Jun 30, 2025
  2. Alkermes ALKS public float $4.7B, Jun 30, 2025
  3. Lantheus Holdings LNTH public float $4.3B, Jun 30, 2025
  4. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  5. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.